These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31671326)

  • 1. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis.
    Xu XM; Wei YD; Liu Y; Li ZX
    Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
    Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
    Scrima L; Hartman PG; Johnson FH; Hiller FC
    Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
    Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
    Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium oxybate for cataplexy.
    Lemon MD; Strain JD; Farver DK
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
    Alshaikh MK; Tricco AC; Tashkandi M; Mamdani M; Straus SE; BaHammam AS
    J Clin Sleep Med; 2012 Aug; 8(4):451-8. PubMed ID: 22893778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1979 Feb; 6(1):1-6. PubMed ID: 264152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
    Mamelak M; Scharf MB; Woods M
    Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S; Quera-Salva MA; Machou M
    J Clin Sleep Med; 2011 Dec; 7(6):667-8. PubMed ID: 22171208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK; Roth T; Schwartz J; Miloslavsky M
    J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
    Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
    Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.